Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm.
Direct-to-consumer genomic testing is available to anyone willing to pay for it. We investigated the reliability and reproducibility of such testing by sending DNA samples to 2 popular companies and by reviewing current literature on this topic. The concerns that were initially raised about direct-to- consumer genomic testing still seem valid.